Abstract

ObjectiveThis review was done to determine the prevalence of metabolic syndrome (MS) among adult general population in India. We also wanted to find the gender, setting, and region-wide distribution of MS in India.MethodsWe conducted systematic searches in various databases including Medline, ScienceDirect, Cochrane library and Google Scholar from inception until August 2019. We included studies conducted in India reporting the prevalence of MS among adults aged 18 years or more. We used the Newcastle Ottawa scale to assess the quality of included studies. We carried out a meta-analysis with random-effects model and reported pooled prevalence with 95% confidence intervals (CIs). We used the Funnel plot to assess publication biases.ResultsIn total, we analysed 113 data from 111 studies with 133,926 participants. Majority of the included studies (76 out of 111) had low risk of bias. We found significant heterogeneity among the included studies (p<0.001). We also found a symmetrical funnel plot indicating an absence of publication bias. The prevalence of MS among adult population in India was 30% (95%CI: 28%-33%). There was a steady increase in the burden across the age groups from 13% (18–29 years group) to 50% (50–59 years). We also found that people living in urban areas (32%; 95%CI: 29%-36%) had higher prevalence when compared to tribal (28%; 95%CI: 21%-36%) or rural adults (22%; 95%CI: 20%-25%). Gender distribution of MS showed that the females had higher prevalence (35%; 95%CI: 31%-38%) when compared to males 26% (95%CI: 22%-29%).ConclusionAlmost one in three adults in India suffer from MS. Females, people living in urban areas and in northeast region had higher prevalence of MS. Development and implementation of policies and protocols for the screening of MS would enable us in early diagnosis and treatment with special focus towards the vulnerable and high-risk groups.

Highlights

  • Disease patterns around the globe are undergoing rapid structural changes over the last three decades, with a sudden increase in the burden of Non-Communicable Diseases (NCDs) and a decreasing trend of communicable diseases [1]

  • We found that people living in urban areas (32%; 95%confidence intervals (CIs): 29%-36%) had higher prevalence when compared to tribal (28%; 95%CI: 21%-36%) or rural adults (22%; 95%CI: 20%-25%)

  • Gender distribution of Metabolic Syndrome (MS) showed that the females had higher prevalence (35%; 95%CI: 31%-38%) when compared to males 26% (95%CI: 22%-29%)

Read more

Summary

Introduction

Disease patterns around the globe are undergoing rapid structural changes over the last three decades, with a sudden increase in the burden of Non-Communicable Diseases (NCDs) and a decreasing trend of communicable diseases [1]. The Global Burden of Disease (GBD) study, brings to light this phenomenon of epidemiological transition in India, with a 62.7% of the total mortality in 2016 contributed by the NCDs. Key elements contributing to the development of these NCDs have been identified and are studied together under the heading of Metabolic Syndrome (MS) [2]. Metabolic syndrome is a constellation of interconnected physiological, biochemical, clinical and metabolic factors that directly increases the risk of cardiovascular diseases, type 2 diabetes mellitus (DM) and all-cause mortality. It is constituted by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia [3]. The most widely used ones are from the International Diabetic Federation (IDF) and the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) [4, 5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call